Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia;Allogen stamcelletransplantasjon hos voksne med akutt lymfoblastisk leukemi

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 22, 2008, Pages 2563-2566

  Fløisand, Yngvar ^a   Brinch, Lorentz ^a   Dybedal, Ingunn ^a   Gedde Dahl, Tobias ^a   Heldal, Dag ^a   Holme, Pål André ^a   Egeland, Torstein ^b   Tjønnfjord, Geir E ^b,c  

^a Medisinsk Avdeling ^*

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; REMISSION; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 56749150715     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 782-5.
2. Durrant IJ, Prentice HG, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Br J Haematol 1997; 99: 84-92.
3. Annino L, Vegna ML, Camera A et al. Treatment of adult acute lymphoblastic leukaemia (ALL): longterm follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-71.
4. Thomas X, Boiron JM, Huguet F et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-86.
5. Rowe JM, Buck G, Burnett AK et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005; 106: 3760-7.
6. Tjønnfjord GE, Gedde-Dahl T, Heldal D et al. Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival. Leukemia 2007; 10: 2203-4.
7. Rowe JM, Goldstone AH. How I treat acute lymphocytic leukaemia in adults. Blood 2007; 110: 2268-75.
8. Hammerstrøm J, Ernst P, Lauritzsen GF et al. Handlingsprogram for diagnostikk og behandling av akutt lymfoblastisk leukemi/lymfoblastisk lymfom og Burkitt leukemi/lymfom hos voksne. www.legeforeningen.no/asset/33493/1/33493_1. doc (6.5.2008).
9. Heldal D, Brinch L, Tjønnfjord G et al. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints. Bone Marrow Transplant 2002; 29: 479-86.
10. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
11. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host disease in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-17.
12. Urbano-Ispizua A, Schmitz N, de Witte T et al. Allogeneic and autologous transplantation for hematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639-46.
13. Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572-7.
14. Kiehl MG, Kraut L, Schwerdtfeger R et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first remission. J Clin Oncol 2004; 22: 2816-25.
15. Yanada M, Matsuo K, Suzuki T et al. Allogeneic hematopoietic stem cell transplantation as part of post remission therapy improves survival for adult patients with high-risk acute lymphoblastic leukaemia: a metaanalysis. Cancer 2006; 106: 2657-63.
16. Bruggemann M, Raff T, Flohr T et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006; 107: 1116-23.